Home/Pipeline/Advanced Wound Care Program

Advanced Wound Care Program

Wound Healing

ResearchActive

Key Facts

Indication

Wound Healing

Phase

Research

Status

Active

Company

Ionic Pharmaceuticals

About Ionic Pharmaceuticals

Ionic Pharmaceuticals is a private, preclinical-stage biotech developing a novel nanoparticle drug delivery platform with a claimed 50x improvement in tumor accumulation efficiency. The company, a Boston University spin-out, is applying its materials science expertise across two initial sectors: oncology drug delivery and wound care. Led by a team with prior drug development and commercialization success, including a co-inventor of the blockbuster drug Abraxane, Ionic is currently funded by NIH grants and awards as it works towards commercialization.

View full company profile

Therapeutic Areas

Oncology Wound Care

Other Wound Healing Drugs

Drug	Company	Phase	Status
CYWC628	FibroBiologics	Discovery	Active
BXT-25	BioXyTran	Preclinical	Active
Wound Care Formulations	MediCell Technologies	Commercial	Active
SBX 1977	Stramsen Biotech	Early-stage Clinical	Active
StroMel™ (Planned)	Akan Biosciences	Planned	Active
MRG-001	MedRegen	Phase 2	Active (Study Completed, Data Pending)
CordLining Stem Cell Therapy	CellResearchCorp	Phase 1	Active
ABCcolla® Collagen Matrix	ACRO Biomedical	Commercial	Active